The FDA recently approved duloxetine hydrochloride to treat chronic musculoskeletal pain, including discomfort from osteoarthritis and chronic lower back pain, according to an FDA press release. Read more »
FDA panel backs wider use of Eli Lilly’s Cymbalta – CNN Money
BETHESDA, Md. (Reuters) - Eli Lilly and Co's antidepressant Cymbalta should be approved to help ease chronic pain in certain patients, a U.S Read more »
FDA panel mixed on approving Cymbalta for pain – AP – msnbc.com
A majority of federal health advisers say a best-selling antidepressant from Eli Lilly & Co. appears effective in treating back pain, but not arthritis. The Food and Drug Administration is considering whether to broaden ... Read more »
FDA cancels meeting to review Lilly’s antidepressant as a new pain treatment (Minneapolis-St. Paul Star Tribune)
WASHINGTON - The Food and Drug Administration has canceled a meeting to review Eli Lilly's antidepressant Cymbalta for a new use against chronic pain. Read more »
